Hydrocortisone sodium succinate 100 mg / 2mL Injection 2 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 69097-0004-67 |
|---|---|
| Product NDC | 69097-0004 |
| Generic Drug Name | Hydrocortisone sodium succinate |
| Brand Name | Hydrocortisone sodium succinate |
| Manufacturer | Cipla USA Inc. |
| Strength | 100 mg / 2mL |
| Dosage Form | Injection |
| Drug Type | Intramuscular; Intravenous |
| Package Quantity | 1 Vial |
| Package Description | 1 VIAL in 1 CARTON (69097-004-67) / 2 mL in 1 VIAL |
| Active Ingredients | Hydrocortisone Sodium Succinate |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Hydrocortisone sodium succinate 100 mg / 2mL Injection is tracked under NDC 69097-0004-67 and rolls up into product family 69097-0004. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 1 Vial.
- Manufacturer: Cipla USA Inc..
- Dosage form: Injection.
- Family size: 1 indexed presentation.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Potential alternatives with matching presentation
Open the comparison hub or review package-level listings from 5 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.
View Potential Alternative Hubhydrocortisone sodium succinate 100 mg / 2mL Injection 2 mL Vial5 package-level listings in the comparison hub.Sample package-level pages in this comparison set
Drug Shortage Information
Documented shortage history shows hydrocortisone sodium succinate appeared in resolved shortage postings in 2023 and again in 2025, suggesting elevated future supply risk.
Drug Shortage Index family
View Hydrocortisone sodium succinate in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Hydrocortisone sodium succinate.Source: Public FDA drug shortage records accessed through FDA-owned openFDA drug shortages queries.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Hydrocortisone sodium succinate 100 mg / 2mL Injection 2 mL, NDC 69097-0004-67, is a Cipla USA Inc. 100 mg / 2mL injection presentation packaged as 1 Vial. Historical public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 69097-0004-67
- Digits-only NDC 11: 69097000467
- Possible 10-digit display format: 69097-004-67 (6909700467)
Helpful product links
- Search by brand name: Hydrocortisone sodium succinate
- NDC 11: 69097-0004-67
- Product family NDC: 69097-0004
- VA classification code: HS051
- VA classification code description: GLUCOCORTICOIDS
- CMOP ID: H0589
- VUID: 4002933
- UNSPSC code: 51422434
- Misc. Order Numbers: 1265368